Financial Data and Key Metrics Changes - Owlet achieved record annual revenue of $105.7 million for 2025, representing a 35.4% increase compared to 2024 [10][24] - Q4 2025 revenue was $26.6 million, up 29.6% year-over-year, driven by growth across the Dream product suite and Owlet360 subscription [10][23] - Full year 2025 gross margin was a record 50.6%, despite a 510 basis point impact from tariffs [10][24] - Adjusted EBITDA for Q4 was $0.1 million, down from $0.5 million in Q4 2024, while full year 2025 Adjusted EBITDA reached a record $2 million, improving by $3.8 million over 2024 [10][11][25] Business Line Data and Key Metrics Changes - The Owlet360 subscription service crossed 110,000 paying subscribers, contributing to the company's growth strategy [5][17] - Dream Sock and Duo demonstrated strong domestic year-over-year sell-through at 9% and 53% respectively, indicating robust demand [12] - International revenue for Q4 reached $3.9 million, with full year 2025 international revenue at $19.2 million, up 27% versus 2024 [14][15] Market Data and Key Metrics Changes - Owlet expanded its market share in baby monitors to 41% in Q4 2025, a 24% increase compared to Q4 2024 [13] - Consumer spending on baby monitors in 2025 was the highest in the last five years, indicating a growing market [13] - International sell-through remains strong, with significant growth in the U.K. (58%), France (41%), and the Nordics (80%) compared to Q4 2024 [15] Company Strategy and Development Direction - The company aims to drive global adoption of Dream Sock, expand the Owlet360 subscription platform, grow healthcare channels, and launch the Owlet telehealth platform [11][19] - Owlet is focusing on integrating AI across its platforms to enhance its competitive edge and improve customer experiences [18] - The company is positioned to capture the Gen Z and young millennial demographic, where connected wearable devices are already a baseline expectation [8][9] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in strong performance and growth into 2026, despite challenges such as tariffs and macroeconomic pressures [11][30] - The company anticipates revenue for Q1 2026 in the range of $20 million-$21 million, with full year 2026 revenue expected to be between $126 million-$130 million, representing growth of 19%-23% over 2025 [27][28] - Management highlighted the importance of the pediatric telehealth opportunity, which could significantly enhance care quality and patient outcomes [20] Other Important Information - Owlet's cash and cash equivalents as of December 31, 2025, were $35.5 million, up from $23.8 million in the previous quarter [26] - The company has received regulatory clearance for Dream Sock sales in India and Israel, expanding its international growth potential [15][16] Q&A Session Summary Question: Guidance for Q1 and full year expectations - Management noted that Q1 is typically the lightest revenue contributor due to seasonality and observed softness in consumer spending [33] - Confidence in the full year guidance reflects strong long-term demand despite a lighter Q1 [34] Question: Generative AI insights and their impact - Management discussed leveraging AI for real-time personalized insights and enhancing subscription features, which will drive stickiness [36] Question: International expansion and subscription progress - Management expects international revenue to begin in the first half of the year, with strong sell-through in European markets [41] - The guidance does not include material contributions from new countries or telehealth opportunities, indicating potential upside [42] Question: Go-to-market strategy for telehealth offering - The telehealth platform will be an upsell to Owlet360, with a focus on getting the experience right before launching in the second half of 2026 [47] Question: Churn rate for Owlet360 subscribers - Management reported positive trends in subscriber growth, retention, and metrics indicating improved stickiness [50] Question: Long-term view on international revenue - Management sees significant growth opportunities in international markets, particularly in regions with high birth rates [59]

Financial Data and Key Metrics Changes - For the full year 2025, net sales increased by 4.4% to $600 million, marking consecutive growth [4][25] - Gross margin expanded by 30 basis points to 57.3%, despite facing tariff headwinds that negatively impacted margins by approximately 100 basis points [7][26] - Adjusted EBITDA for the year was $19.7 million, or 3.3% of net sales, down from $23.3 million or 4.1% the previous year [26] Business Line Data and Key Metrics Changes - The U.S. region, the largest market, saw net sales growth of 7% to $394 million, accounting for 66% of total business [5] - Princess Polly delivered double-digit net sales growth, with a successful omni-channel expansion strategy, including the opening of 7 new stores in the U.S. [5][10] - Petal & Pup performed well, particularly in dresses and event wear, and expanded its wholesale presence, especially at Nordstrom [15][17] Market Data and Key Metrics Changes - Net sales in Australia increased by 1.6% to $58.1 million, indicating a return to growth in the region [23] - Total orders increased by 6.4% year-over-year, reaching 2.2 million [24] Company Strategy and Development Direction - The company aims to attract and retain customers through direct consumer channels, expand brand awareness via physical retail and strategic wholesale partnerships, and streamline operations [8][9] - AI integration is a key focus to enhance customer experience and operational excellence, with expectations for significant margin expansion in the coming years [9] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's position for accelerated growth and expanding margins entering 2026, with a focus on operational discipline and inventory health [8][30] - The company anticipates net sales for fiscal 2026 to be between $625 million and $635 million, representing growth of 4.2% to 5.8% [28] Other Important Information - The company completed a structural transformation of its supply chain, with approximately 50% of U.S. sourcing now from outside China [6] - Inventory levels decreased by 10% year-over-year, reflecting improved inventory management practices [28] Q&A Session Summary Question: Can you walk us through the key drivers of the EBITDA guide for 2026? - Management indicated that the bulk of the expected EBITDA improvement will come from gross margin expansion, moving past the previous year's headwinds [34][35] Question: What percentage of revenue now comes from retail, and how does it compare to direct-to-consumer growth? - Management noted strong productivity in retail stores and indicated that store openings are expected to continue driving new customer acquisition [38][39] Question: How do you envision the business retail versus wholesale for Princess Polly? - Management highlighted the opportunity for growth in both retail and wholesale, with a focus on expanding the store footprint for Princess Polly and wholesale for Petal & Pup [43][45] Question: How are you thinking of the cadence with top line and adjusted EBITDA? - Management explained that they expect mid-single digit growth for the full year, with a more challenging comparison in the first quarter due to previous disruptions [47][48] Question: Can you provide more detail on the inventory situation? - Management confirmed that inventory is down 10%, attributing this to improved sourcing and inventory management practices [51][52] Question: Is the Australian market back to growth? - Management confirmed that the Australian market has seen four consecutive quarters of growth, with expectations for moderate growth moving forward [54][55]

Financial Data and Key Metrics Changes - For the full year 2025, revenue reached $560 million, exceeding guidance, while adjusted EBITDA was $70 million, landing in the upper half of the range [5][19] - Fourth quarter revenues decreased by 14% to $145 million, with grill revenues down 22% to $61 million, primarily due to elasticity and unfavorable mix shifts [21][22] - Adjusted EBITDA for the fourth quarter increased 6% to $19 million compared to $18 million in the same period of 2024, demonstrating operating leverage despite lower revenue levels [23] Business Line Data and Key Metrics Changes - Consumables revenues grew by 16% to $36 million, driven by higher unit volumes across wood pellets and food consumables [22] - Accessories revenues fell by 18% to $49 million, pressured by negative sales growth at MEATER [22] - The pellets business performed well, indicating strong consumer engagement and supporting long-term health and replacement outlook [9] Market Data and Key Metrics Changes - The outdoor grilling market has been relatively steady since 2022, reflecting only modest declines, with the company holding market share despite a sluggish category backdrop [7][9] - Connected cooks increased by 11% year-over-year during the holiday season, indicating strong brand engagement [7] Company Strategy and Development Direction - The company is focused on Project Gravity, a multi-year initiative aimed at reshaping the business, simplifying operations, and improving profitability [11][14] - The strategy includes exiting lower return revenue streams, optimizing channel strategy, and reallocating resources to high-return opportunities [11][12] - The company plans to launch two additional products in 2026 at more accessible price points to expand household penetration [8] Management's Comments on Operating Environment and Future Outlook - Management noted that tariffs had a significant impact on the category, driving volatility in ordering behavior, but they managed to protect profitability through disciplined pricing and cost control [10][20] - For fiscal year 2026, the company is guiding revenue of $465 million-$485 million and adjusted EBITDA of $50 million-$60 million, reflecting a transition year with a focus on long-term growth [17][29] - Management expressed confidence in the brand's strength and the potential for market recovery, although they have not forecasted a return to normalized replacement cycles [36][37] Other Important Information - The company exited fiscal year 2025 with cash and cash equivalents of $20 million and total net debt of $384 million, a decrease of $10 million from the previous year [24] - Project Gravity is expected to deliver approximately $64 million-$70 million of total value across both phases, with benefits beginning to materialize in 2025 and continuing into 2026 [14] Q&A Session Summary Question: Where did the grill market finish in 2025 relative to 2019 levels in terms of industry volumes? - Management indicated that the market has been modestly down in recent years, with expectations for recovery as consumers approach replacement cycles [35][36] Question: What is the expected revenue impact from the DTC exit? - The revenue impact from exiting DTC and other initiatives is around $70 million, with margin rate pressure due to tariffs and promotional deleverage [39][40] Question: Can you elaborate on SKU rationalization efforts? - The company aims to streamline the product portfolio to create efficiencies in manufacturing and inventory while enhancing consumer decision-making clarity [44][45] Question: How is the company addressing ongoing MEATER pressure? - Management is centralizing MEATER operations and leveraging fixed cost infrastructure to drive ongoing growth while managing inventory health [58][59] Question: What is the reason for the similar decremental margin despite Project Gravity? - The decremental margin remains similar due to full-year tariff impacts and promotional deleverage, which are expected to improve as revenue normalizes [63][64]

Financial Data and Key Metrics Changes - The reported net loss for the full year 2025 is approximately $63.5 million, which is $45 million higher than in 2024, primarily due to non-cash charges linked to rising stock prices and an asset impairment charge [31][39] - Total revenues for the fourth quarter were approximately $6.6 million, a net increase of $3.7 million compared to the same period in 2024, driven by higher collaboration revenue from Roche [33] - Total operating expenses for the fourth quarter were $13.2 million, an increase of $5.2 million compared to the same period in 2024 [34] Business Line Data and Key Metrics Changes - R&D expenses for the fourth quarter were $8.2 million, an increase of $4.8 million compared to the same period in 2024, driven by costs associated with the OpRegen program and other preclinical programs [34][38] - G&A expenses for the fourth quarter were approximately $4.8 million, an increase of $0.4 million compared to the same period in 2024, primarily due to personnel costs [34] Market Data and Key Metrics Changes - The company has achieved a significant milestone under its Roche Genentech alliance, which has led to the opening of 10 new clinical sites for the GALE study in the past nine months, indicating positive forward progress [8][14] Company Strategy and Development Direction - The company is focused on delivering the next wave of innovation in cell therapy, particularly in areas outside of oncology, with a strong emphasis on the OpRegen program for dry AMD [5][7] - The AlloSCOPE platform is being utilized to scale pluripotent cells for various applications, aiming to address challenges in manufacturing and supply for cell therapies [10][22] - A new research initiative in type one diabetes has been announced, with the company achieving its initial go/no-go development milestone, indicating a commitment to solving supply issues in islet cell transplants [23][24] Management's Comments on Operating Environment and Future Outlook - Management remains confident in the potential for OpRegen to drive positive clinical outcomes and is encouraged by the commitment from partners [41] - The company is optimistic about the scalability of its manufacturing processes and the potential to develop additional cell-based products [12][29] Other Important Information - The company has a cash position of $55.8 million as of December 31, 2025, which, along with recent warrant exercises, is expected to support operations into Q2 of 2028 [32] - The company has identified a significant opportunity in the islet cell transplant space, focusing on overcoming supply challenges to create a commercially viable product [24][28] Q&A Session Summary Question: Strategic business development with various cell types and AlloSCOPE - The company is leveraging its AlloSCOPE platform to generate a basket of assets and is mindful of cost of capital and risk in its business development strategy [44][46] Question: Rate-limiting steps for islet cell component scale-up - The transition from half-liter to larger scales presents challenges, but the company is optimistic about achieving control in lower mid-liter scales [47][49] Question: Timing of functional measures in OPC1 program - The OPC1 study is primarily a safety and performance study, with functional assessments occurring at one year rather than earlier [61][62] Question: Potential for four-year data on OpRegen - The company is excited about the durability of benefits seen in OpRegen but does not have information on the plans for four-year data from its partner [59] Question: Learnings from islet cell research and Roche partnership - The inverted risk approach is being applied to the islet cell initiative, with insights gained from various programs contributing to the development strategy [73][74]

Financial Data and Key Metrics Changes - For the full year of 2025, the company reported revenue of $161 million, an increase of 849% compared to the previous year, with a loss from operations of $20 million, down by $71 million [18][19] - Non-GAAP Adjusted EBITDA for 2025 was $16 million, an increase of $74 million year-over-year, with Q4 2025 showing nearly $8 million in Adjusted EBITDA [10][19] - The company turned positive on cash flows from operations in Q4, generating $20 million during the period, and increased cash equivalents and restricted cash to $117 million at year-end, a $9 million increase from Q3 [18][19] Business Line Data and Key Metrics Changes - Gevo North Dakota achieved a record-setting biofuel production of approximately 69 million gallons of ethanol in 2025, while capturing 173,000 metric tons of carbon dioxide [10][22] - The company plans to expand capacity at Gevo North Dakota to 75 million gallons per year and increase carbon sequestration to at least 200,000 metric tons annually [10][24] Market Data and Key Metrics Changes - The company reported that about 80% of carbon benefits remained attached to ethanol sold into low carbon fuel markets, with an inventory of roughly 30,000 tons of Carbon Dioxide Removal credits by the end of Q4 [12] - The customer base for CDR credits has expanded to include companies like PayPal and Bank of Montreal, indicating a growing market demand [12] Company Strategy and Development Direction - The company is focused on its Alcohol-to-Jet (ATJ) project, referred to as Project North Star, which aims to deliver $150 million in Adjusted EBITDA per year once constructed [13][14] - Gevo is pursuing a franchise model to deploy similar plants globally, leveraging its intellectual property and business system [14][16] - The company is also exploring partnerships for carbon management services and transportation of third-party carbon dioxide [16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's position and growth potential, highlighting the successful integration of Red Trail Energy assets and the positive cash flow achieved [5][10] - The outlook for 2026 includes a target of approximately $40 million in annualized non-GAAP Adjusted EBITDA and a neutral to positive operating cash flow [19][21] Other Important Information - The company has a conditional commitment from the U.S. Department of Energy for a loan guarantee to finance the construction of the ATJ plant [17] - Management emphasized the importance of proven technologies and experienced engineers in the development of the ATJ project, differentiating it from other industry projects [82][83] Q&A Session Questions and Answers Question: Changes in CI calculations and their impact - Management indicated that changes to the CI score would reduce it by 6 to 7 points, potentially generating an incremental $0.10 per gallon in 2026 [29][30] Question: Status of ATJ project financing and FID - Management confirmed ongoing discussions with the DOE for an extension and expressed optimism about securing financing for the ATJ project [31][34] Question: Path to $40 million in EBITDA - Management outlined that the trajectory is on track for approximately $10 million in Adjusted EBITDA per quarter, driven by existing assets and carbon monetization [41][43] Question: Potential acquisitions - Management is looking for similar assets to Gevo North Dakota that can leverage their expertise and business model [44][46] Question: Voluntary CDR market pricing outlook - Management noted that pricing in the voluntary CDR market typically ranges from $100 to $300 per ton, with competition increasing from low carbon fuel markets [98][99]

Financial Data and Key Metrics Changes - Revenues for Q4 2025 increased to $75.4 million, up from $73 million in Q4 2024, representing a growth of 5.6% on a comparable basis [3] - Adjusted EBITDA for Q4 2025 rose to $10.7 million, compared to $10.4 million in Q4 2024, marking a slight increase [3] - For the full year, revenues and adjusted property EBITDA at American Place reached $124 million and $34.3 million, reflecting increases of 13% and 17% respectively [4] Business Line Data and Key Metrics Changes - At American Place, revenues increased by 11% to $32 million in Q4 2025, with adjusted property EBITDA rising 29% to $8.7 million [4] - Chaminade's revenue growth in the second half of 2025 was 5% compared to the same period in 2024, with adjusted property EBITDA improving significantly [7] - Silver Slipper and Rising Star properties experienced slight declines in revenue for the quarter, while management changes are expected to drive growth in 2026 [11][12] Market Data and Key Metrics Changes - The market for American Place is described as under-penetrated, with the closest competitor generating half a billion dollars annually in gaming revenue [5][6] - The company is strategically located near a population of over 1 million people, which is expected to drive future growth [5] Company Strategy and Development Direction - The company plans to continue focusing on the growth of American Place, with expectations of reaching a run rate EBITDA of $50 million for the temporary facility and $100 million for the permanent facility [5] - Management changes at Chaminade are aimed at improving operations and profitability, with a focus on enhancing marketing efforts [7][9] - The company is also exploring new marketing strategies, including targeted advertising and loyalty programs, to increase customer engagement [10][59] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the long-term potential of American Place, citing the under-penetrated market and strong demographic support [5][6] - The company acknowledged challenges in the competitive landscape but remains optimistic about future growth driven by improved management and marketing strategies [6][10] - Management noted that the Illinois operations are generating sufficient cash flow to cover interest expenses on current debt [12] Other Important Information - The company has approximately $51 million in liquidity at the end of the quarter, including the undrawn portion of its revolving credit facility [12] - A bill to extend the operational date of the temporary casino is expected to pass in the Illinois legislature, which would facilitate a smooth transition to the permanent facility [14] Q&A Session Summary Question: What is the outlook for Chaminade given the recent revenue trends? - Management explained that previous revenue spikes were due to inefficient marketing, and with a new management team in place, they expect revenue growth to improve moving forward [20][21] Question: Have there been any signs of re-acceleration in Q1 2026? - Management confirmed that there has been some improvement in revenue despite minor disruptions from renovations [22] Question: What is the status of the Rising Sun property and the Indiana bill? - Management indicated that while they continue to make money at Rising Sun, the legislative process for relocation is complex and may face challenges [35][36] Question: Can you provide an update on the financing for the American Place project? - Management stated that they are in discussions for financing that will not involve equity sales and are confident in securing a deal soon [44][45] Question: What is the growth strategy for the Silver Slipper property? - Management noted that while the property has been stable, they are implementing management changes to enhance efficiency and profitability [75][76]

Financial Data and Key Metrics Changes - Owlet achieved revenue of $26.6 million in Q4 2025, a 29.6% increase compared to Q4 2024, concluding a record year with total revenue of $105.7 million for 2025, representing a 35.4% growth over 2024 [9][22] - Q4 gross margins were 47.6%, impacted by tariffs, while full year 2025 gross margins reached a record 50.6% [9][23] - Adjusted EBITDA for Q4 was $0.1 million, down from $0.5 million in Q4 2024, while full year 2025 Adjusted EBITDA was a record $2 million, improving by $3.8 million over 2024 [10][24] Business Line Data and Key Metrics Changes - The Owlet360 subscription service crossed 110,000 paying subscribers, contributing to revenue growth and enhancing customer relationships [5][15] - The Dream product suite, including the new Dream Sight camera, showed strong sales momentum, with Dream Sock and Duo experiencing year-over-year sell-through increases of 9% and 53% respectively [11][12] Market Data and Key Metrics Changes - Owlet expanded its market share in the baby monitor category to 41% in Q4 2025, a 24% increase compared to Q4 2024, with overall consumer spending on baby monitors at a five-year high [12] - International revenue reached $3.9 million in Q4, totaling $19.2 million for the year, a 27% increase from 2024, despite a decline in Q4 due to a shift in revenue recognition [13] Company Strategy and Development Direction - The company aims to drive global adoption of Dream Sock, expand the Owlet360 subscription platform, grow healthcare channels, and launch the Owlet telehealth platform [10][18] - Owlet is focusing on integrating AI across its platforms to enhance its competitive edge and provide personalized experiences for parents [16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in strong performance and growth into 2026, despite challenges such as tariff impacts and macroeconomic pressures [10][28] - The company anticipates another record year in 2026, with revenue expectations between $126 million and $130 million, representing a growth of 19%-23% over 2025 [27] Other Important Information - Owlet's cash and cash equivalents were $35.5 million at the end of Q4, up from $23.8 million in Q3, indicating improved liquidity [25] - The company is investing in R&D to enhance software and services for its subscription and telehealth offerings [27] Q&A Session Summary Question: Guidance for Q1 and revenue expectations - Management noted that Q1 is typically the lowest revenue quarter due to seasonality and a strong prior year, but remains confident in long-term demand [31][33] Question: Details on generative AI insights - The company plans to leverage AI for personalized sleep coaching and actionable insights, enhancing the subscription features [34][35] Question: International expansion and subscription progress - Revenue from new international markets is expected to begin in the first half of the year, with strong sell-through in existing European markets [39][40] Question: Go-to-market strategy for telehealth offering - The telehealth platform will be an upsell to Owlet360, with a focus on refining the user experience before a full launch [44] Question: Churn rate for Owlet360 subscribers - Management reported improving retention rates and positive trends in subscriber metrics, indicating strong customer engagement [47]

Financial Data and Key Metrics Changes - For Q4 2025, the company recorded revenue of $6 million, a 43% increase from CAD 4.2 million in Q4 2024 [4][5] - Gross margin in Q4 2025 was 67%, down from 71% in Q4 2024, primarily due to product mix and introductory pricing in new markets [5] - The net loss for Q4 2025 was CAD 8.2 million or CAD 0.27 per share, compared to a net loss of CAD 4.9 million or CAD 0.20 per share in Q4 2024 [5][6] - As of December 31, 2025, the company had cash of $59.7 million, with expectations of declining cash burn and eventual cash flow positivity [6] Business Line Data and Key Metrics Changes - Recurring revenue for Q4 2025 was $2.3 million, while one-time sales of capital equipment accounted for $3.7 million [4] - The company had 78 TULSA-PRO sites as of December 31, 2025, with a growing sales pipeline of 110 new systems [20] Market Data and Key Metrics Changes - The company is seeing broader adoption of TULSA-PRO across both academic and community hospitals, driven by increased awareness of clinical benefits and established reimbursement pathways [20] - TULSA reimbursement was confirmed for 2026 at Urology level 7, with expectations of coverage decisions from private insurance carriers in the second half of 2026 [21] Company Strategy and Development Direction - The company aims to establish TULSA as a third distinct category in prostate cancer treatment, offering both whole-gland and focal treatment options [25][26] - The strategy includes focusing on existing MR installations and achieving an install base of 200 TULSA-PRO sites, with plans for compatibility with new Siemens interventional MR technology [37] - The introduction of the TULSA-AI Volume Reduction module is expected to enhance BPH treatment efficiency and expand the total addressable market [33][42] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving high double-digit to low triple-digit revenue growth, supported by upcoming catalysts and a strong sales pipeline [22][43] - The company is on a path to profitable growth, with projections indicating that revenues of $80 million to $85 million could lead to profitability [76] Other Important Information - The CAPTAIN trial, a significant clinical study, is expected to provide important data that could influence reimbursement timelines and treatment paradigms [72][74] - The company is also exploring opportunities with its Sonalleve technology, which is being used for various treatments, including for adenomyosis and pancreatic cancer [40][41] Q&A Session Summary Question: Update on private payers and reimbursement - Management noted that the number of patients going through private payers is increasing, with typical payments between 1.5 to 2.5 times Medicare rates, and over 90% of rejections are being tracked for potential reversal [44][46] Question: Dynamics of non-capital revenue decline - Management clarified that the 20% growth mentioned was year-over-year, not quarter-over-quarter, and that the mix of capital versus recurring revenue is expected to shift as the install base grows [49][50] Question: Expectations for 2026 revenue growth - Management did not provide specific guidance but indicated confidence in achieving a range of 90% to 110% growth based on site additions and overall market dynamics [62][63] Question: Progress on CAPTAIN trial data release - Management expects that early dissemination of CAPTAIN trial data will enhance confidence in reimbursement decisions and emphasized the integrity of the trial data [72][74] Question: Cash flow positivity timeline - Management indicated a trend of decreasing cash burn, projecting that reaching revenues of $80 million to $85 million would lead to cash flow positivity [76] Question: Installation pacing for TULSA systems - Management suggested that installations would increase throughout the year, with a standardized approach to announcing numbers expected [82][83] Question: Usage of the BPH module - At least 10 sites have started using the BPH module, with expectations for rapid growth in adoption [89] Question: International expansion progress - Management confirmed ongoing interest in international markets, with distributor agreements in place and a careful strategy for growth outside the U.S. [91][92]

Financial Data and Key Metrics Changes - For fiscal year 2025, net sales increased by 4.4% to $600 million, marking consecutive growth [4][24] - Gross margin expanded by 30 basis points to 57.3%, despite facing tariff headwinds that negatively impacted margins by approximately 100 basis points [8][25] - Adjusted EBITDA for the year was $19.7 million, or 3.3% of net sales, down from $23.3 million or 4.1% the previous year [25] Business Line Data and Key Metrics Changes - The U.S. region, the largest market, saw net sales growth of 7% to $394 million, accounting for 66% of total business [5] - Princess Polly, the largest brand, achieved double-digit net sales growth, supported by its omni-channel expansion strategy [11] - Petal & Pup performed well, particularly in dresses and event wear, and expanded its wholesale presence [15] Market Data and Key Metrics Changes - Net sales in Australia increased by 1.6% to $58.1 million, indicating a stable market performance [22] - Total orders rose by 6.4% year-over-year to 2.2 million, with active customers increasing to 4.18 million [23] Company Strategy and Development Direction - The company aims to attract and retain customers through direct consumer channels and exclusive merchandising [9] - Expansion of brand awareness through physical retail and strategic wholesale partnerships is a key focus [9] - The integration of AI across the organization is expected to enhance customer experience and operational efficiency [10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's momentum, with first-quarter net sales growth tracking in the mid-single digits [9][22] - The outlook for fiscal 2026 anticipates net sales between $625 million and $635 million, representing growth of 4.2% to 5.8% [26] - The company is positioned for accelerated growth and improved profitability due to supply chain diversification and inventory discipline [28] Other Important Information - The company completed a structural transformation of its supply chain, with approximately 50% of U.S. sourcing now from outside China [6] - Inventory levels decreased by 10% year-over-year, reflecting improved inventory management practices [26] Q&A Session Summary Question: What are the key drivers for the EBITDA guidance for 2026? - Management indicated that the majority of the EBITDA improvement will come from gross margin expansion, moving past the previous year's headwinds [31][33] Question: What percentage of revenue now comes from retail? - Management confirmed strong performance in retail, with significant productivity in Princess Polly stores and plans for further store openings [35][37] Question: How do you envision the business retail versus wholesale? - Management sees opportunities for growth across all channels, with a focus on expanding the store footprint for Princess Polly and wholesale for Petal & Pup [41][43] Question: What is the outlook for inventory management? - Management highlighted a 10% reduction in inventory while growing the business, emphasizing a strategy of lower inventory growth relative to sales growth [51][52] Question: How is the Australian market performing? - Management reported four consecutive quarters of growth in Australia, with expectations for moderate growth moving forward [53][54]

Financial Data and Key Metrics Changes - The company reported a debt-free status and strengthened working capital for the full year 2025, with improved royalties when adjusted for one-time licensee events [4][6][7] - A private placement of $1.1 million was completed at $1 per share, indicating a strategic move to reinforce the balance sheet [5][6] Business Line Data and Key Metrics Changes - The automotive pipeline has seen meaningful expansion, with Ferrari and Cadillac entering the market with SPD-SmartGlass, and Mercedes showcasing SPD in a concept vehicle [3][12][13] - The transition of Ferrari's business to Isoclima was successful, with Isoclima exceeding minimum annual royalty thresholds despite challenges in the supply chain [11][12] Market Data and Key Metrics Changes - The architectural retrofit market is identified as a significant opportunity, with the company launching a retrofit architectural SPD product at GlassBuild America [16][17] - The installed base of buildings globally is much larger than annual new construction, expanding the addressable market for SPD retrofit systems [17] Company Strategy and Development Direction - The company is focusing on expanding its automotive programs and architectural retrofit initiatives, with a broader pipeline than ever before [15][27] - New product developments include advancements in SPD black technology and new SPD film variants, driven by OEM feedback [15][16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the operational continuity of SPD production and program execution despite Gauzy's restructuring efforts [19][24] - The company anticipates meaningful revenue growth from automotive programs as integration progresses, with a strong pipeline and validated technology across multiple OEMs [25][27][28] Other Important Information - Gauzy's French subsidiaries are undergoing a court-supervised rehabilitation, but this does not affect the German SPD film production facility or the SPD emulsion production in Israel [8][19] - The company remains in regular contact with Gauzy, ensuring that production and program execution continue despite the restructuring [10][19] Q&A Session Summary Question: Concerns about Gauzy's French rehabilitation proceeding - Management indicated that the situation is improving and that the rehabilitation process applies only to Gauzy's French subsidiaries, with production continuing elsewhere [18][19] Question: Impact of war on operations - Management acknowledged disruptions due to the war but noted that operations are resuming as airspace reopens [20][54] Question: Concerns about Gauzy's financial distress affecting business - Management reassured that customers are not expressing concerns about Gauzy's viability, and long-term contracts remain in place [50] Question: Justification for recent capital raise - Management explained that the capital raise was necessary due to unpaid receivables and supply disruptions, emphasizing the need for liquidity to execute the business plan [60][73] Question: Timeline for retrofit projects - Management confirmed that retrofit projects have already started and are being developed alongside ancillary systems [82][84] Question: Interest from Ferrari in expanding SPD roofs - Management confirmed that Ferrari has expressed interest in expanding SPD roofs to other models [88] Question: Inquiry about the LG project - Management declined to provide specifics on the LG project but offered to discuss it privately [91][93]